Company Analysis

Sunshine Biopharma Inc. (SBFM)

Nasdaq: SBFM · Pharmaceutical Preparations · Fort Lauderdale, FL · filing with the SEC since 2007
Grade4.7
◀ Past 3.6● Present 5.8▶ Future 4.2
2 est.

Who owns Sunshine Biopharma Inc.

As filed with the SEC
Holders of 5% or more
2
Mitchell P. Kopin holds 9.99% of Common stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
1
report now, of 10 people on the record since 2009. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Mitchell P. Kopin
SCHEDULE 13G/A · filed Aug 13, 2026 · Common stock, par value $0.001 per share · 9.99% in May 23, 2025
9.99%
CVI Investments, Inc.
SCHEDULE 13G · filed Oct 13, 2026 · Common Stock, $0.001 par value per share
9.9%
Bigger Michael
SCHEDULE 13G · filed May 21, 2026 · Common Stock, $0.001 par value · reported falling below 5%, from 0% in Jun 12, 2025
under 5%
BJI Financial Group
SCHEDULE 13G · filed Oct 14, 2026 · Common Stock .0001 · reported falling below 5%
under 5%
L1 Capital Global Opportunities Master Fund, Ltd.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Units, $ 0.001 par value · reported falling below 5%, from 5.83% in May 22, 2026
under 5%
Alta Partners LLC
SCHEDULE 13G/A · filed Oct 5, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 8.6% in Jul 8, 2026
under 5%
Altium Capital Management LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.001 par value · reported falling below 5%
under 5%
What SBFM reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Nora Pharma
A company bought · acquisition · owns, named in the 10-K filed Apr 3, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
162224
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton SBFM · research, not advice